128 related articles for article (PubMed ID: 7824544)
1. Can posttreatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice.
Kuribara H
Pharmacol Biochem Behav; 1994 Oct; 49(2):323-6. PubMed ID: 7824544
[TBL] [Abstract][Full Text] [Related]
2. Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice.
Kuribara H; Uchihashi Y
Pharmacol Biochem Behav; 1994 Jan; 47(1):101-6. PubMed ID: 8115410
[TBL] [Abstract][Full Text] [Related]
3. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice.
Kuribara H; Uchihashi Y
J Pharm Pharmacol; 1993 Dec; 45(12):1042-5. PubMed ID: 7908972
[TBL] [Abstract][Full Text] [Related]
4. Modification of cocaine sensitization by dopamine D1 and D2 receptor antagonists in terms of ambulation in mice.
Kuribara H
Pharmacol Biochem Behav; 1995 Aug; 51(4):799-805. PubMed ID: 7675862
[TBL] [Abstract][Full Text] [Related]
5. Effects of YM-09151-2, a potent and selective dopamine D2 antagonist, on the ambulation-increasing effect of methamphetamine in mice.
Kuribara H; Tadokoro S
Jpn J Pharmacol; 1990 Mar; 52(3):489-92. PubMed ID: 1970609
[TBL] [Abstract][Full Text] [Related]
6. Effects of sulpiride and nemonapride, benzamide derivatives having distinct potencies of antagonistic action on dopamine D2 receptors, on sensitization to methamphetamine in mice.
Kuribara H
J Pharm Pharmacol; 1996 Mar; 48(3):292-6. PubMed ID: 8737056
[TBL] [Abstract][Full Text] [Related]
7. Caffeine enhances the stimulant effect of methamphetamine, but may not affect induction of methamphetamine sensitization of ambulation in mice.
Kuribara H
Psychopharmacology (Berl); 1994 Oct; 116(2):125-9. PubMed ID: 7862940
[TBL] [Abstract][Full Text] [Related]
8. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice.
Kuribara H
Eur J Pharmacol; 1995 Mar; 275(3):251-8. PubMed ID: 7768292
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice.
Kuribara H
Pharmacol Biochem Behav; 1995 Dec; 52(4):759-63. PubMed ID: 8587917
[TBL] [Abstract][Full Text] [Related]
10. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol and restraint differently inhibit the induction of sensitization to the ambulation-increasing effect of methamphetamine in mice.
Kuribara H
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):253-63. PubMed ID: 7584719
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
Usuda S; Nishikori K; Noshiro O; Maeno H
Psychopharmacology (Berl); 1981; 73(2):103-9. PubMed ID: 6112770
[TBL] [Abstract][Full Text] [Related]
13. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA
Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of behavioural stimulant effect of N-cyanomethylmethamphetamine, a main product of smoking methamphetamine mixed with tobacco: evaluation by ambulatory activity in mice.
Kuribara H; Sekine H; Nakahara Y
Pharmacol Toxicol; 1996 Jun; 78(6):374-80. PubMed ID: 8829196
[TBL] [Abstract][Full Text] [Related]
15. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.
Nikaido T; Akiyama M; Moriya T; Shibata S
Mol Pharmacol; 2001 Apr; 59(4):894-900. PubMed ID: 11259635
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.
Kuribara H
Psychopharmacology (Berl); 1995 Jul; 120(1):75-80. PubMed ID: 7480538
[TBL] [Abstract][Full Text] [Related]
17. Effects of haloperidol on the methamphetamine sensitization: assessment by ambulatory activity in mice.
Kuribara H; Uchihashi Y
Jpn J Psychiatry Neurol; 1993 Sep; 47(3):661-8. PubMed ID: 8301885
[TBL] [Abstract][Full Text] [Related]
18. SCH 23390 equivalently, but YM-09151-2 differentially reduces the stimulant effects of methamphetamine, MK-801 and ketamine: assessment by discrete shuttle avoidance in mice.
Kuribara H; Uchihashi Y
Jpn J Pharmacol; 1993 May; 62(1):111-4. PubMed ID: 8101884
[TBL] [Abstract][Full Text] [Related]
19. [Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance after repeated administration of methamphetamine by means of the ambulation-increasing effect in mice].
Uchihashi Y; Morimoto T; Tadokoro S
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):153-60. PubMed ID: 1505855
[TBL] [Abstract][Full Text] [Related]
20. Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice.
Kuribara H
Eur J Pharmacol; 1994 May; 256(3):295-9. PubMed ID: 8045274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
